methylprednisolone has been researched along with allopurinol in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (25.45) | 18.7374 |
1990's | 13 (23.64) | 18.2507 |
2000's | 12 (21.82) | 29.6817 |
2010's | 14 (25.45) | 24.3611 |
2020's | 2 (3.64) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Lillehei, RC; MacCarter, DJ; Shatney, CH | 1 |
Najarian, JS; Simmons, RL; Toledo-Pereyra, LH | 2 |
Glaumann, B | 1 |
Kokas, P; Kupcsulik, P | 1 |
Najarian, JS; Tersigni, R; Toledo-Pereyra, LH | 1 |
Berne, TV; Chatterjee, SN | 1 |
Bouchouareb, D; Moulin, B; Ollier, J; Olmer, M; Purgus, R | 1 |
Chang, YC; Hayashi, T; Kohno, H; Nagasue, N; Nakamura, T; Yamanoi, A | 1 |
Bjertnaes, L; Ingebrigtsen, T; Kjaeve, J; Naess, L; Vaage, J | 2 |
Hosoya, T; Ishida, Y; Kobayashi, M; Ohno, I; Sakai, O | 1 |
Callahan, AS; Christie-Pope, BC; Eddy, LJ; Palmer, GC; Palmer, SJ; Taylor, MD | 1 |
Eddy, LJ; Mellert, TK; Parmentier, JL; Taylor, MD | 1 |
Moberg, AW; Najarian, JS; Toledo-Pereyra, LH | 1 |
Campos, RA; Moberg, AW; Mozes, MF; Najarian, JS; Toledo-Pereyra, LH | 1 |
Ignarro, LJ | 1 |
Benoit, P; Langlois, RP; Mongeau, JG; O'Regan, S; Robitaille, PO | 1 |
Schneider, U; Schwenk, HU | 1 |
Bronsther, OL; Demetris, A; Fung, J; Pinna, AD; Rao, PN; Snyder, J; Starzl, TE | 1 |
Cai, M; Ogawa, R | 1 |
Boros, M; Karácsony, G; Kaszaki, J; Nagy, S | 1 |
Fábián, G; Magyarlaki, T; Nagy, J; Rumi, G; Sámik, J; Szöke, B | 1 |
Mann, DS; Yale, ES; Yale, SH | 1 |
Bushell, A; Davies, H; Grierson, I; Jackson, MJ; Klenerman, L | 1 |
Brinkmann, S; Dimmeler, S; Neugebauer, E | 1 |
Augustin, AJ; Grus, FH; Lutz, J; Sekundo, W; Spitznas, M; Zimmermann, CW | 1 |
Augustin, AJ; Grus, FH; Loeffler, K; Sekundo, W | 1 |
Baskin, E; Cila, A; Eren, M; Ozen, S | 1 |
Cabrer, K; Fuster, J; García-Valdecasas, JC; González, FX; Grande, L; López-Boado, MA; Momblan, D; Rull, R; Vidal, O; Visa, J | 1 |
Altinoz, E; Ates, O; Cakir, CO; Cayli, SR; Karadag, N; Kocak, A; Yologlu, S; Yucel, N | 1 |
Altinoz, E; Ates, O; Cayli, S; Gurses, I; Kocak, A; Turkoz, Y; Yologlu, S; Yucel, N | 1 |
Bru, I; De Muynck, M; Decorte, T; Rimbaut, S; Van Maele, G; Vanden Bossche, LC; Vanderstraeten, G; Wojtowicz, I | 1 |
Arias-Santiago, S; Husein-Elahmed, H; Orgaz-Molina, J; Soriano-Hernández, MI | 1 |
Chiang, YY; Chin, SY; Huang, YC; Shih, PY | 1 |
Aihara, M; Isoda, Y; Kambara, T; Matsukura, S; Morita, A; Watanabe, Y | 1 |
Pirisi, M; Rossi, L; Sainaghi, PP; Sola, D | 1 |
Arıkök, AT; Ergüder, BI; Gürer, B; Kanat, MA; Kertmen, H; Sanlı, AM; Sargon, MF; Sekerci, Z; Sorar, M; Yılmaz, ER | 1 |
Li, Y; Luo, D; Xia, J; Xu, J; Yin, Z | 1 |
Dikicier, BS; Erdem, T; Kara, RO; Solak, B | 1 |
Ha, JW; Hahm, JE; Kim, CW; Kim, SS; Lee, JY; Lee, SY | 1 |
Arıkök, AT; Bektaşoğlu, PK; Çelikoğlu, E; Ergüder, Bİ; Gürer, B; Kanat, MA; Karakoç, A; Kertmen, H; Öztürk, ÖÇ; Sargon, MF | 1 |
Arisanti, R; Parlindungan, F; Setiyohadi, B | 1 |
Broglie, L; Dorrello, NV; Hijiya, N; Kaur, D; Pavisic, J; Phillips, L | 1 |
2 review(s) available for methylprednisolone and allopurinol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Leishmaniasis: a rare cause of unexplained fever in a renal graft recipient.
Topics: Adult; Allopurinol; Animals; Antimony; Antiprotozoal Agents; Graft Rejection; Humans; Immunosuppression Therapy; Kidney Transplantation; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Methylprednisolone; Muromonab-CD3; Organometallic Compounds | 1992 |
53 other study(ies) available for methylprednisolone and allopurinol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Effects of allopurinol, propranolol and methylprednisolone on infarct size in experimental myocardial infarction.
Topics: Allopurinol; Animals; Blood; Coronary Disease; Disease Models, Animal; Dogs; Heart; Hemodynamics; Hydrogen-Ion Concentration; Methylprednisolone; Myocardial Infarction; Myocardium; Oxygen; Propranolol | 1976 |
Factors determining successful liver preservation for transplantation.
Topics: Allopurinol; Ammonia; Animals; Aspartate Aminotransferases; Bilirubin; Cold Temperature; Cryoglobulins; Dogs; Female; Fractional Precipitation; Gels; Glucose; L-Lactate Dehydrogenase; Liver; Liver Transplantation; Male; Methylprednisolone; Organ Preservation; Osmolar Concentration; Perfusion; Serum Albumin; Silicon Dioxide; Tissue Preservation; Transplantation, Homologous | 1975 |
Effect of mannitol, dextran (macrodex), allopurinol, and methylprednisolone on the morphology of the proximal tubule of the rat kidney made ischemic in vivo.
Topics: Allopurinol; Animals; Dextrans; Ischemia; Kidney Tubules, Proximal; Male; Mannitol; Methylprednisolone; Microscopy, Electron; Necrosis; Rats; Shock | 1977 |
Ischemic damage of the liver. Part II: In vivo investigation of the prevention of the ischemic lesion of the liver.
Topics: Adenosine Triphosphate; Allopurinol; Animals; Aspartic Acid; Chlorides; Glucagon; Ischemia; Liver; Liver Regeneration; Magnesium; Methylprednisolone; Phenoxybenzamine; Rats | 1979 |
Effects of methylprednisolone, glucagon, and allopurinol in the protection of pancreaticoduodenal allografts perfused for twenty-four hours.
Topics: Allopurinol; Animals; Dogs; Duodenum; Glucagon; Methylprednisolone; Organ Preservation; Pancreas; Pancreas Transplantation; Perfusion; Tissue Preservation; Tissue Survival; Transplantation, Homologous | 1975 |
Use of cellular membrane stabilizers to prevent ischemic damage to the kidneys.
Topics: Allopurinol; Animals; Dogs; Ischemia; Kidney; Methylprednisolone; Uremia | 1975 |
Attenuation of ischemia-reperfusion injury of the liver in dogs by cyclosporine. A comparative study with allopurinol and methylprednisolone.
Topics: Allopurinol; Animals; Aspartate Aminotransferases; Cyclosporins; Dogs; Female; L-Lactate Dehydrogenase; Liver; Male; Methylprednisolone; Reperfusion Injury | 1991 |
Toxic oxygen metabolites increase microvascular permeability in isolated perfused rat lungs: the effect of methylprednisolone.
Topics: Animals; Capillary Permeability; Hypoxanthine; Hypoxanthines; Lung; Male; Methylprednisolone; Oxygen; Rats; Rats, Inbred Strains; Xanthine Oxidase | 1991 |
[Allopurinol induced aplastic anemia in a patient with chronic renal failure].
Topics: Adult; Allopurinol; Anemia, Aplastic; Blood Transfusion; Bone Marrow Transplantation; Female; Humans; Kidney Failure, Chronic; Methylprednisolone; Polycystic Kidney Diseases | 1990 |
Classification of ischemic-induced damage to Na+, K+-ATPase in gerbil forebrain. Modification by therapeutic agents.
Topics: Adenosine Triphosphatases; Allopurinol; Animals; Brain; Brain Ischemia; Ca(2+) Mg(2+)-ATPase; Calcium-Transporting ATPases; Clonazepam; Egtazic Acid; Female; Gerbillinae; Indomethacin; Methylprednisolone; Sodium-Potassium-Exchanging ATPase; Thiopental; Time Factors | 1985 |
Pharmacological protection of reoxygenation damage to in vitro brain slice tissue.
Topics: Allopurinol; Animals; Brain Chemistry; Cell Survival; Evoked Potentials; Hippocampus; Hypoxia, Brain; Indomethacin; Male; Methylprednisolone; Oxygen Consumption; Rats; Sodium-Potassium-Exchanging ATPase; Time Factors | 1985 |
Optimal management of warm ischemic kidneys prior to hypothermic preservation.
Topics: Allopurinol; Animals; Cadaver; Cold Temperature; Diuretics; Dogs; Humans; Ischemia; Kidney; Kidney Transplantation; Methylprednisolone; Organ Preservation; Perfusion; Phenoxybenzamine; Phentolamine; Tissue Preservation | 1974 |
Prevention of irreversible ischemic damage in renal preservation by pharmacological manipulation.
Topics: Allopurinol; Animals; Chlorpromazine; Dogs; Hypothermia; Ischemia; Kidney Transplantation; Methylprednisolone; Phenoxybenzamine; Tissue Preservation; Tissue Survival; Transplantation, Autologous | 1974 |
Comparative effects of chlorpromazine, methylprednisolone, and allopurinol during small bowel preservation.
Topics: Allopurinol; Animals; Chlorpromazine; Dogs; Injections, Intravenous; Intestine, Small; Ischemia; Methylprednisolone; Perfusion; Tissue Preservation; Tissue Survival; Transplantation, Homologous | 1973 |
Release of neutral protease and beta-glucuronidase from human neutrophils in the presence of cartilage treated with various immunologic reactants.
Topics: Allopurinol; Arthritis, Rheumatoid; Aspirin; Cartilage; Chloroquine; Colchicine; Factor VIII; Glucuronidase; Hot Temperature; Humans; Immunoglobulin G; Indomethacin; Iodine Radioisotopes; L-Lactate Dehydrogenase; Methylprednisolone; Neutrophils; Peptide Hydrolases; Probenecid; Protein Denaturation; Sulfur Radioisotopes; Synovial Fluid; Triamcinolone Acetonide; Vinblastine | 1974 |
Hyperacute azotemia caused by cell lysis in leukemia.
Topics: Allopurinol; Antineoplastic Agents; Child; Humans; Leukemia, Lymphoid; Male; Methylprednisolone; Prednisone; Uremia; Water-Electrolyte Imbalance | 1981 |
[Life-threatening hyperuricemia during cytostatic leukemia therapy].
Topics: Adolescent; Allopurinol; Asparaginase; Child; Humans; Leukemia, Lymphoid; Male; Methylprednisolone; Pentamidine; Pulmonary Fibrosis; Uric Acid; Vincristine | 1982 |
Prediction of early graft function by effluent levels of hyaluronic acid in clinical liver transplantation.
Topics: Adenosine; Allopurinol; Biomarkers; Cyclosporine; False Negative Reactions; False Positive Reactions; Glutathione; Graft Survival; Humans; Hyaluronic Acid; Insulin; Liver; Liver Transplantation; Methylprednisolone; Organ Preservation; Organ Preservation Solutions; Prognosis; Raffinose; Reperfusion; Solutions; Steroids; Tacrolimus | 1993 |
Effects of free radical scavengers, methylprednisolone, and ulinastatin on acute xanthine and xanthine oxidase-induced lung injury in rats.
Topics: Animals; Disease Models, Animal; Free Radical Scavengers; Glycoproteins; Infusions, Intravenous; Lung; Male; Methylprednisolone; Organ Size; Rats; Rats, Wistar; Respiratory Distress Syndrome; Thiobarbituric Acid Reactive Substances; Xanthine; Xanthine Oxidase; Xanthines | 1994 |
Reperfusion mucosal damage after complete intestinal ischemia in the dog: the effects of antioxidant and phospholipase A2 inhibitor therapy.
Topics: Allopurinol; Animals; Antioxidants; Dexamethasone; Dogs; Female; Ileum; Intestinal Mucosa; Ischemia; Male; Methylprednisolone; Phospholipases A; Phospholipases A2; Quinacrine; Quinolines; Reperfusion Injury | 1993 |
[Chronic IgM mesangioproliferative glomerulonephritis].
Topics: Adult; Allopurinol; Angiotensin-Converting Enzyme Inhibitors; Antimetabolites; Ascorbic Acid; Biopsy; Child; Chronic Disease; Drug Combinations; Drug Therapy, Combination; Glomerulonephritis, Membranoproliferative; Glucocorticoids; Humans; Immunoglobulin M; Male; Methylprednisolone; Prognosis; Radioisotope Renography; Rutin | 1995 |
Fever, rash, and angioedema after a course of allopurinol.
Topics: Allopurinol; Angioedema; Anti-Inflammatory Agents; Drug Eruptions; Fever; Gout Suppressants; Humans; Male; Methylprednisolone; Middle Aged | 1996 |
Ischemia-reperfusion-induced muscle damage. Protective effect of corticosteroids and antioxidants in rabbits.
Topics: Allopurinol; Animals; Anti-Inflammatory Agents; Antimetabolites; Antioxidants; Ascorbic Acid; Ischemia; Methylprednisolone; Methylprednisolone Acetate; Muscles; Rabbits; Reperfusion Injury | 1996 |
Methylprednisolone attenuates airway and vascular responses induced by reactive oxygen species in isolated, plasma-perfused rat lungs.
Topics: Animals; Blood Pressure; Bronchoconstriction; Hypoxanthine; Kinetics; Lung; Male; Methylprednisolone; Perfusion; Rats; Rats, Wistar; Reactive Oxygen Species; Respiratory Distress Syndrome; Vasoconstriction; Xanthine Oxidase | 1996 |
Endotoxin-induced changes of endothelial cell viability and permeability: protective effect of a 21-aminosteroid.
Topics: Allopurinol; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aorta; Ascorbic Acid; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Endotoxins; Lipopolysaccharides; Methylprednisolone; Oxidative Stress; Pregnatrienes; Structure-Activity Relationship; Swine; Vitamin E | 1995 |
Immunomodulating activity of allopurinol in experimental lens-induced uveitis.
Topics: Adjuvants, Immunologic; Allopurinol; Animals; Antimetabolites; Autoantibodies; Autoantigens; Blotting, Western; Crystallins; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Therapy, Combination; Electrophoresis, Polyacrylamide Gel; Glucocorticoids; Male; Methylprednisolone; Rats; Rats, Wistar; Uveitis | 1997 |
[Immunological effect of systemically administered allopurinol in experimental autoimmune uveitis].
Topics: Allopurinol; Animals; Anti-Inflammatory Agents; Autoantibodies; Autoimmune Diseases; Blotting, Western; Dose-Response Relationship, Drug; Free Radical Scavengers; Immune Tolerance; Injections, Intravenous; Male; Methylprednisolone; Rats; Rats, Inbred Lew; Retina; Uveitis | 2000 |
Mannitol treatment in central nervous system lupus.
Topics: Administration, Oral; Allopurinol; Brain Ischemia; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Injections, Intravenous; Lupus Nephritis; Lupus Vasculitis, Central Nervous System; Magnetic Resonance Imaging; Mannitol; Methylprednisolone; Prednisolone; Treatment Outcome | 2001 |
Evaluation of potential liver donors: expanding donor criteria?
Topics: Adenosine; Adolescent; Adult; Age Factors; Allopurinol; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Glutathione; Humans; Immunosuppressive Agents; Infant; Insulin; Liver; Liver Transplantation; Methylprednisolone; Organ Preservation; Organ Preservation Solutions; Probability; Raffinose; Survival Rate; Time Factors | 2002 |
Neuroprotective effect of etomidate on functional recovery in experimental spinal cord injury.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Drug Therapy, Combination; Etomidate; Female; Glutathione; Laminectomy; Malondialdehyde; Methylprednisolone; Motor Activity; Neuroprotective Agents; Nitric Oxide; Random Allocation; Rats; Recovery of Function; Spinal Cord Injuries; Statistics, Nonparametric; Xanthine Oxidase | 2006 |
Effects of resveratrol and methylprednisolone on biochemical, neurobehavioral and histopathological recovery after experimental spinal cord injury.
Topics: Animals; Glutathione; Male; Malondialdehyde; Methylprednisolone; Motor Activity; Neuroprotective Agents; Nitric Oxide; Rats; Rats, Wistar; Resveratrol; Spinal Cord; Spinal Cord Injuries; Stilbenes; Xanthine Oxidase | 2006 |
Free radical scavengers versus methylprednisolone in the prevention of experimentally induced heterotopic ossification.
Topics: Acetylcysteine; Allopurinol; Animals; Disease Models, Animal; Female; Free Radical Scavengers; Glucocorticoids; Hindlimb Suspension; Methylprednisolone; Ossification, Heterotopic; Placebos; Rabbits; Radiography | 2009 |
[Angioedema due to losartan].
Topics: Aged; Allopurinol; Angioedema; Angiotensin II Type 2 Receptor Blockers; Bradykinin; Diphenhydramine; Humans; Losartan; Male; Methylprednisolone | 2011 |
Allopurinol-induced drug rash with eosinophilia and systemic symptoms mimicking acute generalized exanthematous pustulosis.
Topics: Acute Generalized Exanthematous Pustulosis; Aged; Allopurinol; Diagnosis, Differential; Drug Hypersensitivity Syndrome; Glucocorticoids; Gout Suppressants; Humans; Male; Methylprednisolone | 2012 |
A case of toxic epidermal necrolysis induced by allopurinol with human herpesvirus-6 reactivation.
Topics: Aged; Allopurinol; Biopsy; Combined Modality Therapy; Fatal Outcome; Female; Glucocorticoids; Gout Suppressants; Herpesvirus 6, Human; Humans; Immunoglobulins, Intravenous; Methylprednisolone; Plasmapheresis; Pulse Therapy, Drug; Roseolovirus Infections; Sepsis; Skin; Stevens-Johnson Syndrome; Time Factors; Treatment Outcome; Virus Activation | 2013 |
DRESS syndrome with cerebral vasculitis.
Topics: Adult; Allopurinol; Antitubercular Agents; Diagnosis, Differential; Drug Hypersensitivity Syndrome; Humans; Hyperuricemia; Magnetic Resonance Imaging; Male; Methylprednisolone; Tuberculosis, Pulmonary; Vasculitis, Central Nervous System | 2013 |
The protective effect of low-dose methotrexate on ischemia-reperfusion injury of the rabbit spinal cord.
Topics: Animals; Caspase 3; Catalase; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Malondialdehyde; Methotrexate; Methylprednisolone; Peroxidase; Rabbits; Reperfusion Injury; Spinal Cord; Xanthine Oxidase | 2013 |
Transient hypofibrinogenemia due to allopurinol.
Topics: Administration, Oral; Afibrinogenemia; Aged, 80 and over; Allopurinol; Drug Eruptions; Fibrinogen; Humans; Infusions, Intravenous; Male; Methylprednisolone | 2014 |
DRESS syndrome potentially induced by allopurinol and triggered by influenza vaccine.
Topics: Allopurinol; Drug Hypersensitivity Syndrome; Exanthema; Female; Herpesvirus 6, Human; Humans; Influenza Vaccines; Methylprednisolone; Middle Aged; Treatment Outcome; Virus Activation | 2016 |
Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allopurinol; Anticonvulsants; Antitubercular Agents; Carbamazepine; Drug Hypersensitivity Syndrome; Eosinophilia; Female; Glucocorticoids; Gout Suppressants; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Male; Methylprednisolone; Middle Aged; Prednisone; Republic of Korea; Retrospective Studies; Severity of Illness Index; Thrombocytopenia; Time Factors; Young Adult | 2017 |
Comparative effects of vitamin D and methylprednisolone against ischemia/reperfusion injury of rabbit spinal cords.
Topics: Animals; Caspase 3; Catalase; Disease Models, Animal; Male; Malondialdehyde; Methylprednisolone; Peroxidase; Rabbits; Reperfusion Injury; Spinal Cord Ischemia; Vitamin D; Xanthine Oxidase | 2017 |
Disseminated Cutaneous Tophi in a Patient with Chronic Tophaceous Gout and Renal Impairment: A Case Report of a Rare Manifestation of Gout.
Topics: Allopurinol; Arthritis, Gouty; Biomarkers; Colchicine; Glucocorticoids; Gout Suppressants; Humans; Male; Methylprednisolone; Middle Aged; Renal Insufficiency; Skin Diseases | 2020 |
Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia.
Topics: Adolescent; Allopurinol; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Betacoronavirus; Combined Modality Therapy; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Daunorubicin; Fluid Therapy; Humans; Male; Methylprednisolone; Nitriles; Pandemics; Pneumonia, Viral; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrazoles; Pyrimidines; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Vincristine | 2020 |